首页> 外国专利> Hepatitis Virus Culture Systems Using Stem Cell-Derived Human Hepatocyte-Like Cells and Their Methods of Use

Hepatitis Virus Culture Systems Using Stem Cell-Derived Human Hepatocyte-Like Cells and Their Methods of Use

机译:使用干细胞样人肝细胞样细胞的肝炎病毒培养系统及其使用方法

摘要

The invention relates to the discovery that DHH derived from stem cells are permissive for infection by hepatitis viruses (HV), such as hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV) and hepatitis E virus (HEV). Included in the invention are HV-permissive DHHs and methods of making an HCV-permissive DHH derived from a stem cell. Also included is an HV culture system comprising at least one HV-permissive DHH. The HV-permissive DHH and HV culture system are useful for conducting HV life cycle analyses, diagnosing a subject as being infected with HV, genotyping and characterizing the HV of a subject infected with HV, detecting drug resistance of HV obtained from a subject infected with HV, screening for and identify modulators of HV infection, and monitoring the effect of a treatment of HV in a subject.
机译:本发明涉及以下发现:源自干细胞的DHH允许被甲型肝炎病毒(HAV),乙型肝炎病毒(HBV),丙型肝炎病毒(HCV),丁型肝炎病毒( HDV)和戊型肝炎病毒(HEV)。本发明包括HV允许的DHHs和制备衍生自干细胞的HCV允许的DHH的方法。还包括一种HV培养系统,其包括至少一个HV允许的DHH。允许HV的DHH和HV培养系统可用于进行HV生命周期分析,诊断受HV感染的对象,对HV感染对象的HV进行基因分型和表征,检测从感染HV的对象获得的HV的耐药性HV,筛选和鉴定HV感染的调节剂,并监测受试者中HV的治疗效果。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号